Loading clinical trials...
Loading clinical trials...
A 1-Year Open-Label Safety Extension Study of Pregabalin in Patients With Anxiety Disorders
Conditions
Interventions
Pregabalin
Locations
138
Austria
Pfizer Investigational Site
A-1040 Wien, Austria
Pfizer Investigational Site
Vienna, Austria
Pfizer Investigational Site
Wein, Austria
Pfizer Investigational Site
Brussels, Belgium
Pfizer Investigational Site
De Pinte, Belgium
Pfizer Investigational Site
Ghent, Belgium
Start Date
January 1, 2001
Completion Date
March 1, 2006
Last Updated
July 14, 2006
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions